Loading company details...
Beta
Latest Form 4 (Aug 4, 2026): Roland Wilhelm Kolbeck (Chief Scientific Officer): Exercise/Conversion of 36,375 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Roland Wilhelm Kolbeck, Chief Scientific Officer | Exercise/Conversion | 36,375 | n/a |
| Jun 8, 2026 | Anand Mehra | Exercise/Conversion | 11,580 | n/a |
| Jun 8, 2026 | Andrew N. Schiff | Exercise/Conversion | 11,580 | n/a |
| Jun 8, 2026 | William D. Humphries | Exercise/Conversion | 11,580 | n/a |
| Jun 8, 2026 | Christopher P. Molineaux | Exercise/Conversion | 11,580 | n/a |
| Jun 8, 2026 | Vincent Milano | Exercise/Conversion | 11,580 | n/a |
| Jun 8, 2026 | Maxine Gowen | Exercise/Conversion | 11,580 | n/a |
| May 5, 2026 | Jesse Wayne Hall, Chief Medical Officer | Exercise/Conversion | 36,375 | n/a |
| Apr 27, 2026 | Braden Michael Leonard | Sale | 300,000 | $1.36M |
| Mar 3, 2026 | Kevin Balthaser, Chief Financial Officer | Exercise/Conversion | 2,375 | n/a |